| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5726279 | European Journal of Radiology | 2017 | 9 Pages |
â¢The feasibility of breast PET/MRI has been proven in recent literature.â¢There are technical considerations to be aware of when performing PET/MRI.â¢PET/MRI may be helpful in the future of quantitative and qualitative multiparametric imaging in breast cancer patients.
The future clinical use of the combination of positron emission tomography (PET) with 2-Fluoro[F-18]-2-Deoxy-d-Glucose (FDG)and MRI is still unclear. If a patient requires a PET and breast DCE-MRI for staging purposes, both scans can be done in the same visit. In the breast, DCE-MRI is better at lesion detection (sensitivity), margin evaluation, and has a higher specificity than CT. The potential for multiparametric qualitative and quantitative imaging is also an advantage of PET/MRI which provides opportunity to improve tumor characterization and may ultimately lead to outcome prediction. This review discusses technical and clinical aspects of this emerging technology in breast cancer patients.
